{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:24:55Z","timestamp":1794493495747,"version":"4.9.1"},"reference-count":100,"publisher":"American Society of Hematology","issue":"23","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,12,10]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Analyses of recurrent mutations, copy number alterations, and structural variants reveal complementary immune evasion mechanisms in cHL. The mutational burden in EBV\u2013 cHLs is among the highest reported, potentially contributing to the efficacy of PD-1 blockade.<\/jats:p>","DOI":"10.1182\/bloodadvances.2019001012","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T11:32:36Z","timestamp":1575891156000},"page":"4065-4080","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":165,"title":["Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion"],"prefix":"10.1182","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9548-4420","authenticated-orcid":false,"given":"Kirsty","family":"Wienand","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6485-8773","authenticated-orcid":false,"given":"Bjoern","family":"Chapuy","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Harvard Medical School, Boston, MA;"},{"name":"Department of Hematology and Oncology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2245-9552","authenticated-orcid":false,"given":"Chip","family":"Stewart","sequence":"additional","affiliation":[{"name":"Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6152-3169","authenticated-orcid":false,"given":"Andrew J.","family":"Dunford","sequence":"additional","affiliation":[{"name":"Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7729-5730","authenticated-orcid":false,"given":"David","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, University of Washington, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaegil","family":"Kim","sequence":"additional","affiliation":[{"name":"Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atanas","family":"Kamburov","sequence":"additional","affiliation":[{"name":"Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R.","family":"Wood","sequence":"additional","affiliation":[{"name":"Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5107-0146","authenticated-orcid":false,"given":"Fathima Zumla","family":"Cader","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Ducar","sequence":"additional","affiliation":[{"name":"Department of Data Science, Knowledge Systems Group, Boston, MA;"},{"name":"Center for Cancer Genome Discovery, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron R.","family":"Thorner","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Center for Cancer Genome Discovery, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1947-7429","authenticated-orcid":false,"given":"Anwesha","family":"Nag","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Center for Cancer Genome Discovery, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander T.","family":"Heubeck","sequence":"additional","affiliation":[{"name":"Hematologic Neoplasia Flow Cytometry Core and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Buonopane","sequence":"additional","affiliation":[{"name":"Hematologic Neoplasia Flow Cytometry Core and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1329-5288","authenticated-orcid":false,"given":"Robert A.","family":"Redd","sequence":"additional","affiliation":[{"name":"Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6110-4060","authenticated-orcid":false,"given":"Kamil","family":"Bojarczuk","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7824-9787","authenticated-orcid":false,"given":"Lee N.","family":"Lawton","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6098-1603","authenticated-orcid":false,"given":"Philippe","family":"Armand","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1761-9769","authenticated-orcid":false,"given":"Scott J.","family":"Rodig","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Boston, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2287-5284","authenticated-orcid":false,"given":"Jonathan R.","family":"Fromm","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, University of Washington, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0936-0753","authenticated-orcid":false,"given":"Gad","family":"Getz","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, MA;"},{"name":"Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA;"},{"name":"Department of Pathology and"},{"name":"Center for Cancer Research, Massachusetts General Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3949-6897","authenticated-orcid":false,"given":"Margaret A.","family":"Shipp","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2019,12,9]]},"reference":[{"issue":"3","key":"2019120911323459800_B1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/j.seminhematol.2016.05.007","article-title":"Hodgkin lymphoma: pathology and biology","volume":"53","author":"Mathas","year":"2016","journal-title":"Semin Hematol"},{"issue":"51","key":"2019120911323459800_B2","doi-asserted-by":"crossref","first-page":"20729","DOI":"10.1073\/pnas.1312509110","article-title":"Incomplete cytokinesis and re-fusion of small mononucleated Hodgkin cells lead to giant multinucleated Reed-Sternberg cells","volume":"110","author":"Rengstl","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2019120911323459800_B3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41568-018-0084-6","article-title":"Cytokinesis defects and cancer","volume":"19","author":"Lens","year":"2019","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"2019120911323459800_B4","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1172\/JCI95993","article-title":"Human CD30+ B cells represent a unique subset related to Hodgkin lymphoma cells","volume":"128","author":"Weniger","year":"2018","journal-title":"J Clin Invest"},{"key":"2019120911323459800_B5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.semcancer.2016.05.001","article-title":"NF-\u03baB deregulation in Hodgkin lymphoma","volume":"39","author":"Weniger","year":"2016","journal-title":"Semin Cancer Biol"},{"issue":"7","key":"2019120911323459800_B6","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2014-11-610436","article-title":"Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells","volume":"125","author":"Reichel","year":"2015","journal-title":"Blood"},{"issue":"22","key":"2019120911323459800_B7","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2017-11-814913","article-title":"Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma","volume":"131","author":"Tiacci","year":"2018","journal-title":"Blood"},{"issue":"5","key":"2019120911323459800_B8","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1084\/jem.20090528","article-title":"TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma","volume":"206","author":"Schmitz","year":"2009","journal-title":"J Exp Med"},{"issue":"23","key":"2019120911323459800_B9","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1182\/blood-2012-05-428896","article-title":"Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma","volume":"120","author":"Tiacci","year":"2012","journal-title":"Blood"},{"issue":"22","key":"2019120911323459800_B10","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1182\/blood-2017-11-812073","article-title":"Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma","volume":"131","author":"Spina","year":"2018","journal-title":"Blood"},{"issue":"17","key":"2019120911323459800_B11","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/blood-2010-05-282780","article-title":"Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma","volume":"116","author":"Green","year":"2010","journal-title":"Blood"},{"issue":"23","key":"2019120911323459800_B12","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1200\/JCO.2016.66.4482","article-title":"PD-L1 and PD-L2 genetic alterations define classical Hodgkin lymphoma and predict outcome","volume":"34","author":"Roemer","year":"2016","journal-title":"J Clin Oncol"},{"issue":"9","key":"2019120911323459800_B13","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.3324\/haematol.12875","article-title":"Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin\u2019s lymphoma by array-based comparative genomic hybridization","volume":"93","author":"Hartmann","year":"2008","journal-title":"Haematologica"},{"issue":"10","key":"2019120911323459800_B14","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1158\/1078-0432.CCR-13-3007","article-title":"Selective JAK2 inhibition specifically decreases Hodgkin lymphoma and mediastinal large B-cell lymphoma growth in vitro and in vivo","volume":"20","author":"Hao","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"4","key":"2019120911323459800_B15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1411087","article-title":"PD-1 blockade with nivolumab in relapsed or refractory Hodgkin\u2019s lymphoma","volume":"372","author":"Ansell","year":"2015","journal-title":"N Engl J Med"},{"issue":"14","key":"2019120911323459800_B16","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1200\/JCO.2017.76.0793","article-title":"Nivolumab for relapsed\/refractory classic Hodgkin lymphoma after failure of autologous hematopoietic cell transplantation: extended follow-up of the multicohort single-arm phase II CheckMate 205 trial","volume":"36","author":"Armand","year":"2018","journal-title":"J Clin Oncol"},{"issue":"31","key":"2019120911323459800_B17","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1200\/JCO.2016.67.3467","article-title":"Programmed death-1 blockade with pembrolizumab in patients with classical Hodgkin lymphoma after brentuximab vedotin failure","volume":"34","author":"Armand","year":"2016","journal-title":"J Clin Oncol"},{"issue":"19","key":"2019120911323459800_B18","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1200\/JCO.2016.72.1316","article-title":"Phase II study of the efficacy and safety of pembrolizumab for relapsed\/refractory classic Hodgkin lymphoma","volume":"35","author":"Chen","year":"2017","journal-title":"J Clin Oncol"},{"issue":"23","key":"2019120911323459800_B19","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1200\/JCO.19.00315","article-title":"Nivolumab for newly diagnosed advanced-stage classic Hodgkin lymphoma: safety and efficacy in the phase II CheckMate 205 study","volume":"37","author":"Ramchandren","year":"2019","journal-title":"J Clin Oncol"},{"issue":"11","key":"2019120911323459800_B20","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1158\/2326-6066.CIR-16-0201","article-title":"Classical Hodgkin lymphoma with reduced \u03b22M\/MHC class I expression is associated with inferior outcome independent of 9p24.1 status","volume":"4","author":"Roemer","year":"2016","journal-title":"Cancer Immunol Res"},{"issue":"10","key":"2019120911323459800_B21","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1200\/JCO.2017.77.3994","article-title":"Major histocompatibility complex class II and programmed death ligand 1 expression predict outcome after programmed death 1 blockade in classic Hodgkin lymphoma","volume":"36","author":"Roemer","year":"2018","journal-title":"J Clin Oncol"},{"key":"2019120911323459800_B22","article-title":"Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade [published online ahead of print 28 October 2019]","author":"Chapuy","journal-title":"Blood"},{"issue":"3","key":"2019120911323459800_B23","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ymeth.2012.03.028","article-title":"Strategies for immunophenotyping and purifying classical Hodgkin lymphoma cells from lymph nodes by flow cytometry and flow cytometric cell sorting","volume":"57","author":"Fromm","year":"2012","journal-title":"Methods"},{"issue":"5","key":"2019120911323459800_B24","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1309\/7371XK6F6P7474XX","article-title":"Identification and purification of classical Hodgkin cells from lymph nodes by flow cytometry and flow cytometric cell sorting","volume":"126","author":"Fromm","year":"2006","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"2019120911323459800_B25","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1309\/AJCPW3UN9DYLDSPB","article-title":"Flow cytometry can diagnose classical Hodgkin lymphoma in lymph nodes with high sensitivity and specificity","volume":"131","author":"Fromm","year":"2009","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"2019120911323459800_B26","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"issue":"7","key":"2019120911323459800_B27","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1182\/blood-2015-10-673236","article-title":"Targetable genetic features of primary testicular and primary central nervous system lymphomas","volume":"127","author":"Chapuy","year":"2016","journal-title":"Blood"},{"issue":"18","key":"2019120911323459800_B28","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1093\/bioinformatics\/btr446","article-title":"ContEst: estimating cross-contamination of human samples in next-generation sequencing data","volume":"27","author":"Cibulskis","year":"2011","journal-title":"Bioinformatics"},{"issue":"7","key":"2019120911323459800_B29","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41592-018-0036-9","article-title":"DeTiN: overcoming tumor-in-normal contamination","volume":"15","author":"Taylor-Weiner","year":"2018","journal-title":"Nat Methods"},{"issue":"3","key":"2019120911323459800_B30","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nbt.2514","article-title":"Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples","volume":"31","author":"Cibulskis","year":"2013","journal-title":"Nat Biotechnol"},{"issue":"7457","key":"2019120911323459800_B31","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature12213","article-title":"Mutational heterogeneity in cancer and the search for new cancer-associated genes","volume":"499","author":"Lawrence","year":"2013","journal-title":"Nature"},{"issue":"40","key":"2019120911323459800_B32","doi-asserted-by":"crossref","first-page":"E5486","DOI":"10.1073\/pnas.1516373112","article-title":"Comprehensive assessment of cancer missense mutation clustering in protein structures","volume":"112","author":"Kamburov","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2019120911323459800_B33","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nbt.2203","article-title":"Absolute quantification of somatic DNA alterations in human cancer","volume":"30","author":"Carter","year":"2012","journal-title":"Nat Biotechnol"},{"issue":"3","key":"2019120911323459800_B34","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1093\/nar\/gku1211","article-title":"BreaKmer: detection of structural variation in targeted massively parallel sequencing data using kmers","volume":"43","author":"Abo","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2019120911323459800_B35","doi-asserted-by":"crossref","first-page":"R84","DOI":"10.1186\/gb-2014-15-6-r84","article-title":"LUMPY: a probabilistic framework for structural variant discovery","volume":"15","author":"Layer","year":"2014","journal-title":"Genome Biol"},{"issue":"7333","key":"2019120911323459800_B36","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature09744","article-title":"The genomic complexity of primary human prostate cancer","volume":"470","author":"Berger","year":"2011","journal-title":"Nature"},{"issue":"4","key":"2019120911323459800_B37","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1101\/gr.221028.117","article-title":"SvABA: genome-wide detection of structural variants and indels by local assembly","volume":"28","author":"Wala","year":"2018","journal-title":"Genome Res"},{"issue":"3","key":"2019120911323459800_B38","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ccell.2017.02.010","article-title":"Integrated molecular characterization of uterine carcinosarcoma","volume":"31","author":"Cherniack","year":"2017","journal-title":"Cancer Cell"},{"issue":"6","key":"2019120911323459800_B39","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ccr.2011.11.006","article-title":"Combined genetic inactivation of \u03b22-microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma","volume":"20","author":"Challa-Malladi","year":"2011","journal-title":"Cancer Cell"},{"issue":"11","key":"2019120911323459800_B40","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1084\/jem.20180639","article-title":"Gain-of-function IKBKB mutation causes human combined immune deficiency","volume":"215","author":"Cardinez","year":"2018","journal-title":"J Exp Med"},{"issue":"20","key":"2019120911323459800_B41","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1182\/blood-2009-06-225839","article-title":"Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities","volume":"114","author":"Mottok","year":"2009","journal-title":"Blood"},{"issue":"9","key":"2019120911323459800_B42","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1182\/blood-2007-03-082511","article-title":"Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6","volume":"110","author":"Mottok","year":"2007","journal-title":"Blood"},{"issue":"10","key":"2019120911323459800_B43","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/leu.2009.103","article-title":"STAT6 and STAT1 are essential antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line","volume":"23","author":"Baus","year":"2009","journal-title":"Leukemia"},{"issue":"18","key":"2019120911323459800_B44","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1038\/sj.onc.1209151","article-title":"Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation","volume":"25","author":"Weniger","year":"2006","journal-title":"Oncogene"},{"issue":"1","key":"2019120911323459800_B45","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","article-title":"Genetics of follicular lymphoma transformation","volume":"6","author":"Pasqualucci","year":"2014","journal-title":"Cell Reports"},{"issue":"6","key":"2019120911323459800_B46","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1182\/blood-2009-03-209759","article-title":"Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma","volume":"114","author":"Ritz","year":"2009","journal-title":"Blood"},{"issue":"4","key":"2019120911323459800_B47","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.2900","article-title":"Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma","volume":"46","author":"Gunawardana","year":"2014","journal-title":"Nat Genet"},{"issue":"11","key":"2019120911323459800_B48","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1182\/blood-2016-06-720516","article-title":"A novel PTPN1 splice variant upregulates JAK\/STAT activity in classical Hodgkin lymphoma cells","volume":"129","author":"Zahn","year":"2017","journal-title":"Blood"},{"issue":"9","key":"2019120911323459800_B49","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1038\/leu.2016.95","article-title":"Discovery and functional characterization of a germline, CSF2RB-activating mutation in leukemia","volume":"30","author":"Watanabe-Smith","year":"2016","journal-title":"Leukemia"},{"issue":"1","key":"2019120911323459800_B50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13045-017-0412-4","article-title":"XPO1 in B cell hematological malignancies: from recurrent somatic mutations to targeted therapy","volume":"10","author":"Camus","year":"2017","journal-title":"J Hematol Oncol"},{"key":"2019120911323459800_B51","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cellsig.2018.02.016","article-title":"STAT6 is a cargo of exportin 1: biological relevance in primary mediastinal B-cell lymphoma","volume":"46","author":"Miloudi","year":"2018","journal-title":"Cell Signal"},{"issue":"9","key":"2019120911323459800_B52","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/ajh.24451","article-title":"Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma","volume":"91","author":"Jardin","year":"2016","journal-title":"Am J Hematol"},{"issue":"1","key":"2019120911323459800_B53","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13046-017-0620-3","article-title":"PTEN expression is upregulated by a RNA-binding protein RBM38 via enhancing its mRNA stability in breast cancer","volume":"36","author":"Zhou","year":"2017","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2019120911323459800_B54","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/1471-2407-14-322","article-title":"RNA-binding protein RNPC1: acting as a tumor suppressor in breast cancer","volume":"14","author":"Xue","year":"2014","journal-title":"BMC Cancer"},{"issue":"52","key":"2019120911323459800_B55","doi-asserted-by":"crossref","first-page":"18637","DOI":"10.1073\/pnas.1415607112","article-title":"Mice deficient in Rbm38, a target of the p53 family, are susceptible to accelerated aging and spontaneous tumors","volume":"111","author":"Zhang","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2019120911323459800_B56","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1158\/0008-5472.CAN-17-2457","article-title":"Genetic ablation of Rbm38 promotes lymphomagenesis in the context of mutant p53 by downregulating PTEN","volume":"78","author":"Zhang","year":"2018","journal-title":"Cancer Res"},{"issue":"3","key":"2019120911323459800_B57","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nri3814","article-title":"Germinal centres and B cell lymphomagenesis","volume":"15","author":"Basso","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"7530","key":"2019120911323459800_B58","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nature13765","article-title":"Loss of signalling via G\u03b113 in germinal centre B-cell-derived lymphoma","volume":"516","author":"Muppidi","year":"2014","journal-title":"Nature"},{"issue":"22","key":"2019120911323459800_B59","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1182\/blood-2015-07-659938","article-title":"GNA13 loss in germinal center B cells leads to impaired apoptosis and promotes lymphoma in vivo","volume":"127","author":"Healy","year":"2016","journal-title":"Blood"},{"issue":"1","key":"2019120911323459800_B60","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1038\/s41467-017-01231-x","article-title":"Cytokinesis requires localized \u03b2-actin filament production by an actin isoform specific nucleator","volume":"8","author":"Chen","year":"2017","journal-title":"Nat Commun"},{"issue":"1","key":"2019120911323459800_B61","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/cdd.2008.136","article-title":"Novel cell death by downregulation of eEF1A1 expression in tetraploids","volume":"16","author":"Kobayashi","year":"2009","journal-title":"Cell Death Differ"},{"issue":"10","key":"2019120911323459800_B62","doi-asserted-by":"crossref","first-page":"E1116","DOI":"10.1073\/pnas.1501199112","article-title":"Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation","volume":"112","author":"Green","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6001","key":"2019120911323459800_B63","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.1196333","article-title":"Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma","volume":"330","author":"Jones","year":"2010","journal-title":"Science"},{"issue":"16","key":"2019120911323459800_B64","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","article-title":"ARID1A mutations in endometriosis-associated ovarian carcinomas","volume":"363","author":"Wiegand","year":"2010","journal-title":"N Engl J Med"},{"issue":"12","key":"2019120911323459800_B65","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ng.982","article-title":"Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer","volume":"43","author":"Wang","year":"2011","journal-title":"Nat Genet"},{"issue":"38","key":"2019120911323459800_B66","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1038\/onc.2011.598","article-title":"Mutations and deletions of ARID1A in breast tumors","volume":"31","author":"Cornen","year":"2012","journal-title":"Oncogene"},{"issue":"5","key":"2019120911323459800_B67","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/PAS.0b013e318212782a","article-title":"Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma","volume":"35","author":"Guan","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"21","key":"2019120911323459800_B68","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1158\/0008-5472.CAN-11-1562","article-title":"ARID1A, a factor that promotes formation of SWI\/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers","volume":"71","author":"Guan","year":"2011","journal-title":"Cancer Res"},{"issue":"5","key":"2019120911323459800_B69","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41591-018-0012-z","article-title":"ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade","volume":"24","author":"Shen","year":"2018","journal-title":"Nat Med"},{"issue":"9","key":"2019120911323459800_B70","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S1470-2045(15)00169-2","article-title":"Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry","volume":"16","author":"Pastore","year":"2015","journal-title":"Lancet Oncol"},{"issue":"9","key":"2019120911323459800_B71","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrg3729","article-title":"Mechanisms underlying mutational signatures in human cancers","volume":"15","author":"Helleday","year":"2014","journal-title":"Nat Rev Genet"},{"issue":"6","key":"2019120911323459800_B72","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/ng.3557","article-title":"Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors","volume":"48","author":"Kim","year":"2016","journal-title":"Nat Genet"},{"issue":"9","key":"2019120911323459800_B73","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/ng.2702","article-title":"An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers","volume":"45","author":"Roberts","year":"2013","journal-title":"Nat Genet"},{"issue":"7","key":"2019120911323459800_B74","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1158\/2159-8290.CD-15-0344","article-title":"APOBEC enzymes: mutagenic fuel for cancer evolution and heterogeneity","volume":"5","author":"Swanton","year":"2015","journal-title":"Cancer Discov"},{"issue":"7463","key":"2019120911323459800_B75","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"issue":"4","key":"2019120911323459800_B76","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"Mermel","year":"2011","journal-title":"Genome Biol"},{"issue":"1","key":"2019120911323459800_B77","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/carcin\/bgv165","article-title":"Fine mapping of chromosome 5p15.33 based on a targeted deep sequencing and high density genotyping identifies novel lung cancer susceptibility loci","volume":"37","author":"Kachuri","year":"2016","journal-title":"Carcinogenesis"},{"issue":"1","key":"2019120911323459800_B78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergencyto.2007.12.004","article-title":"Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer","volume":"182","author":"Kang","year":"2008","journal-title":"Cancer Genet Cytogenet"},{"issue":"7","key":"2019120911323459800_B79","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/modpathol.2012.236","article-title":"Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions","volume":"26","author":"Kluth","year":"2013","journal-title":"Mod Pathol"},{"issue":"3","key":"2019120911323459800_B80","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1182\/blood-2009-12-257345","article-title":"Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome","volume":"116","author":"Steidl","year":"2010","journal-title":"Blood"},{"issue":"3","key":"2019120911323459800_B81","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/gcc.22331","article-title":"Recurrent somatic loss of TNFRSF14 in classical Hodgkin lymphoma","volume":"55","author":"Salipante","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"2019120911323459800_B82","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.cell.2016.08.032","article-title":"Loss of the HVEM tumor suppressor in lymphoma and restoration by modified CAR-T cells","volume":"167","author":"Boice","year":"2016","journal-title":"Cell"},{"issue":"8","key":"2019120911323459800_B83","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.leukres.2012.04.010","article-title":"ETV6 fusion genes in hematological malignancies: a review","volume":"36","author":"De Braekeleer","year":"2012","journal-title":"Leuk Res"},{"issue":"10","key":"2019120911323459800_B84","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.3324\/haematol.2014.104406","article-title":"ETV6 mutation in a cohort of 970 patients with hematologic malignancies","volume":"99","author":"Wang","year":"2014","journal-title":"Haematologica"},{"issue":"7338","key":"2019120911323459800_B85","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nature09754","article-title":"MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers","volume":"471","author":"Steidl","year":"2011","journal-title":"Nature"},{"issue":"7","key":"2019120911323459800_B86","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.celrep.2015.10.008","article-title":"Genomic alterations in CIITA are frequent in primary mediastinal large B cell lymphoma and are associated with diminished MHC class II expression","volume":"13","author":"Mottok","year":"2015","journal-title":"Cell Reports"},{"issue":"6","key":"2019120911323459800_B87","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood.V83.6.1595.1595","article-title":"Epstein-Barr virus DNA is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin\u2019s disease: association with mixed cellularity subtype and Hispanic American ethnicity","volume":"83","author":"Gulley","year":"1994","journal-title":"Blood"},{"issue":"3","key":"2019120911323459800_B88","first-page":"549","article-title":"The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain","volume":"10","author":"Huen","year":"1995","journal-title":"Oncogene"},{"issue":"10","key":"2019120911323459800_B89","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1172\/JCI61245","article-title":"Hodgkin lymphoma","volume":"122","author":"K\u00fcppers","year":"2012","journal-title":"J Clin Invest"},{"issue":"4","key":"2019120911323459800_B90","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1182\/blood.V86.4.1464.bloodjournal8641464","article-title":"Numerical chromosome aberrations are present within the CD30+ Hodgkin and Reed-Sternberg cells in 100% of analyzed cases of Hodgkin\u2019s disease","volume":"86","author":"Weber-Matthiesen","year":"1995","journal-title":"Blood"},{"issue":"12","key":"2019120911323459800_B91","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","article-title":"The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma","volume":"102","author":"Savage","year":"2003","journal-title":"Blood"},{"issue":"6","key":"2019120911323459800_B92","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":"Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J Exp Med"},{"issue":"4","key":"2019120911323459800_B93","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1182\/blood-2004-12-4901","article-title":"NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes","volume":"106","author":"Feuerhake","year":"2005","journal-title":"Blood"},{"key":"2019120911323459800_B94","article-title":"Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma [published ahead of print 14 October 2019]","author":"Armand","journal-title":"J Clin Oncol"},{"issue":"4","key":"2019120911323459800_B95","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.cell.2017.01.002","article-title":"Endogenous DNA damage as a source of genomic instability in cancer","volume":"168","author":"Tubbs","year":"2017","journal-title":"Cell"},{"issue":"2","key":"2019120911323459800_B96","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1158\/2159-8290.CD-15-0283","article-title":"Loss of PTEN promotes resistance to T cell-mediated immunotherapy","volume":"6","author":"Peng","year":"2016","journal-title":"Cancer Discov"},{"issue":"2","key":"2019120911323459800_B97","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.immuni.2017.02.001","article-title":"Loss of PTEN is associated with resistance to anti-PD-1 checkpoint blockade therapy in metastatic uterine leiomyosarcoma","volume":"46","author":"George","year":"2017","journal-title":"Immunity"},{"issue":"22","key":"2019120911323459800_B98","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1182\/blood-2017-03-770719","article-title":"Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma","volume":"130","author":"Carey","year":"2017","journal-title":"Blood"},{"issue":"8","key":"2019120911323459800_B99","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1182\/blood-2018-04-843714","article-title":"Mass cytometry of Hodgkin lymphoma reveals a CD4+ regulatory T-cell-rich and exhausted T-effector microenvironment","volume":"132","author":"Cader","year":"2018","journal-title":"Blood"},{"issue":"6046","key":"2019120911323459800_B100","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1126\/science.1208130","article-title":"The mutational landscape of head and neck squamous cell carcinoma","volume":"333","author":"Stransky","year":"2011","journal-title":"Science"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/3\/23\/4065\/1546936\/advancesadv2019001012.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/3\/23\/4065\/1546936\/advancesadv2019001012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T11:33:19Z","timestamp":1575891199000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/3\/23\/4065\/429586\/Genomic-analyses-of-flowsorted-Hodgkin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,9]]},"references-count":100,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2019,12,10]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2019001012","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,9]]}}}